These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20640783)

  • 1. Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder.
    Hu JZ; Bai L; Chen DG; Xu QT; Southerland WM
    Interdiscip Sci; 2010 Jun; 2(2):151-6. PubMed ID: 20640783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach.
    Hu Z; Chen D; Dong L; Southerland WM
    Ethn Dis; 2010; 20(1 Suppl 1):S1-45-9. PubMed ID: 20521384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 integrase: the next target for AIDS therapy?
    d'Angelo J; Mouscadet JF; Desmaële D; Zouhiri F; Leh H
    Pathol Biol (Paris); 2001 Apr; 49(3):237-46. PubMed ID: 11367559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M; Debyser Z
    Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
    Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
    J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV activity of medicinal herbs: usage and potential development.
    Wu JA; Attele AS; Zhang L; Yuan CS
    Am J Chin Med; 2001; 29(1):69-81. PubMed ID: 11321482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding aspects of baicalein to HIV-1 integrase.
    Ahn HC; Lee SY; Kim JW; Son WS; Shin CG; Lee BJ
    Mol Cells; 2001 Aug; 12(1):127-30. PubMed ID: 11561722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarins as inhibitors of HIV reverse transcriptase.
    Kostova I
    Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of authentic inhibitors of HIV-1 integration.
    Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
    Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics.
    Young SD
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):402-10. PubMed ID: 11727305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 integration as a target for antiretroviral therapy: a review.
    Pluymers W; De Clercq E; Debyser Z
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):133-49. PubMed ID: 12455410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of integrase inhibitors for treatment of AIDS: an overview.
    Dubey S; Satyanarayana YD; Lavania H
    Eur J Med Chem; 2007 Sep; 42(9):1159-68. PubMed ID: 17367896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.